Improving the outcomes of transplantation with bispecific antibodies
The FORTE clinical trial of carfilzomib in multiple myeloma
The changing role of nurses in bone marrow biopsies
Is inotuzumab ozogamicin with low-dose chemotherapy effective in treating ALL in elderly patients?
The evolving genomic landscape of acute lymphoblastic leukemia (ALL): subtypes, genes and targets